You have long known the values and promises of Dr. Reddy’s Laboratories.

We, as a part of the organization, extend our services into the world of Biologics, standing firm in the same belief that GOOD HEALTH CAN’T WAIT. Our guiding principles and our promises are a continuance of the 40-year-long legacy of Dr Reddy’s.

Dr. Reddy’s Heritage: A Truly Global Company

Years of Dr. Reddy’s Established in 1984 by Dr. Anji Reddy

R&D Centers

Global revenue in FY2024

Manufacturing Sites Including API, finished formulations, and biologics

Countries, a felt global presence

Employees from 50+ nationalities

Patients access our therapies every year

of the global revenue invested in Research and Development

We Are One.
United in Our Passion for Care

We at Dr. Reddy’s Biologics enable access to high-quality, cost-competitive biosimilars. The future we imagine is one where patients worldwide find ease in illness, every day. Our state-of-the-art manufacturing facilities and end-to-end capabilities bring this future within reach making us a leading biosimilars manufacturer.

Dr. Reddy’s Biologics Leadership Council

Dr. Jayanth Sridhar

CEO, Global Head of Biologics

(Ph.D in Biochemical Engineering)

With 25 years in biologics, he has led product development and manufacturing across three continents, launching vaccines and biosimilars at Merck, BioMarin, Biocon, and Dr. Reddy’s.

Go Back

Nirmala Raju

Head of Product Development

(Ph.D. in Biochemistry and Biotechnology)

Expert in biosimilars and biologics, specializing in biotechnology with 26 years of experience.
Skilled in cell culture, downstream processes, analytics, bioanalytics, preclinical PK/PD, CMC regulatory affairs, and project management.

Go Back

Narendra Maharaj

Head of Clinical Development

(M.D. in Pharmacology)

With 27 years in clinical development, he leads biologics clinical strategies.
His expertise spans NCEs, NBEs, biosimilars, clinical operations, and project management across multiple therapeutic areas.

Go Back

Ganesh M

Head of Global Parenteral Manufacturing

(M.Sc. in Pharmaceutical Sciences)

35 years of extensive experience in pharmaceutical manufacturing and operations management, leads Global Parenteral Manufacturing at Dr. Reddy's Laboratories.
Brings expertise from key roles at Pfizer, Shasun Chemicals and Drugs, Weikfield Agro, and Unilever.
Ensures compliance with Good Manufacturing Practices (GMP), Lean Manufacturing, Six Sigma, and Regulatory standards.

Go Back

Srikanth Reddy

Head of Quality for Biologics and CGT

(M.Sc. in Microbiology)

Over 17 years of expertise in Quality Management and Assurance, he leads Quality at Dr. Reddy's Biologics & CGT division.
Brings extensive experience from key roles at Sanofi, MSD, GSK, and Novartis, and has been pivotal in advancing Quality Management Systems and securing critical approvals from global regulatory bodies such as MHRA and EMEA.

Go Back

Prasun Guha

Head of Regulatory Affairs

(M.Sc. in Biotechnology)

Pharmaceutical expert with over 20 years in regulatory affairs, secured biosimilar approvals globally, contributing significantly at SciGen BioPharma, Dr. Reddy's, Mylan, and Intas.

Go Back

Aditya Kumar Khanna

Global Head of Alliances, Commercial, Marketing and PMO – Biologics

(MBA in Pharmaceutical Management)

With 20+ years in pharmaceuticals, he leads global alliances and commercial strategy.
His expertise spans marketing, business development, alliance management, and international operations.

Go Back

Shwetanuj Saha

Global Head of Business Development, Strategy and Portfolio – Biologics

(PGDM in Management, Strategy, Marketing and SCM)

A seasoned executive with 17+ years in strategic planning, portfolio management, business development, and management systems.
Leads growth initiatives, bringing expertise from Deloitte and a strong background in pharma consulting.

Go Back

Amit Agarwal

Head of Finance & M&A

(CA)

23+ years of in-depth experience encompassing accounting, auditing, taxation, financial planning & analytics, business strategy, investor relations, ESG, M&A and performance management.
Experienced chartered accountant, worked with Deloitte and since 2007 has been working in different roles with Dr. Reddy’s.

Go Back

Sudeshna Mitra

Head of Human Resources

(MBA in HR and Marketing)

15+ years of experience across talent management, organizational development, and employee experience, shaping HR strategies in Biologics at Dr. Reddy's.

Go Back

Saurabh Biswas

Head of Digital and Process Excellence

(MBA in Advanced Business Analytics, Statistics)

With over a decade of experience at Dr. Reddy’s, he has moved within many roles, shaping a unique career from manager level to the global head of the department.

Go Back

Jerome Gnanaprakasam

Global Head of Projects, Engineering, EHS & Sustainability

(BE in Mechanical Engineering)

34+ years of extensive experience in engineering and capital projects, leads Projects, Engineering, EHS & Sustainability for Global Manufacturing Operations at Dr. Reddy's Laboratories.
Brings expertise from key roles at Glenmark Pharmaceuticals, Actavis (now Allergan), Serum Institute of India Limited, and Biopharm.

Go Back

Mekala Raghava Srinivas

Head of Supply Chain, India

(MBA in Supply Chain & Operations Management)

Over 17 years of experience in pharmaceutical quality management and regulatory compliance, leads Supply Chain India at Dr. Reddy's Laboratories.
Brings expertise from key roles at Flipkart, The Good Stuff Pvt Ltd, Reckitt, and Becton Dickinson.
Recognized for strategic leadership and contributions to elevating organizational quality standards and operational efficiency.

Go Back

Bhupal Reddy Auothu

Head of CAR-T Site

Over 23 years of extensive experience in the biopharmaceutical and cell & gene therapy sectors, leads CAR-T site.
Brings expertise from key roles at GSK, Autolus, and a global network of CDMO/CMOs (Wuxi, Miltenyi, AGC, Samsung Biologics, HCATS/Minerva).
Ensures compliance with Good Manufacturing Practices (GMP), along with strategic Technology Evaluation & Implementation and Manufacturing Scale-Out.

Go Back

Dr. Reddy’s Global Management Council

Read about the leaders of the organisation worldwide at Dr. Reddy’s website.

Know More

Dr. Reddy’s Biologics – Purpose, Promise and History

Our Purpose

Our purpose of accelerating access to affordable and innovative medicines is instructed by our conviction that GOOD HEALTH CAN’T WAIT. With patients at the heart of our efforts, we are dedicated to ensuring they receive the right treatment at the right time – improving their health outcomes. Towards this goal, we strive to create savings within the patient community that can contribute to a sustainable healthcare system by expanding treatment options. Our mission, ultimately, is to enhance access to essential biologic medicines by offering high-quality, cost-effective biosimilars.

Our Promises

Our shared values ensure that any member of our organisation that you meet is upholding our five promises. This is what continues to position us as one of the leaders in biotechnology.

Addressing unmet patient needs

Bringing essential medicines within reach

Ensuring medicines  are available where needed

Working with partners to help them succeed

Helping patients manage disease better

Our History

Our Biologics heritage spans over 25 years since 1998 when Dr. Reddy’s Biologics was first established. Our journey from launching the first biosimilar product in 2001, to today as we invest further in our pipeline of lifesaving biologics and innovations, has unfolded inspiringly.

Commercial Biosimilar Products

Over Countries

Products in Pipeline

patient lives reached

Our Journey

Dr. Reddy’s enters into a collaboration with Henlius for commercialization of HLX15 (daratumumab), a biosimilar candidate to Darzalex® & Darzalex Faspro® in the U.S., and Europe.